As discussed above, various physio-pathological phenomena, such as ageing and hypertension, lead to a marked, time-dependent increase in ang II levels, which exacerbate both local and systemic vascular injury, accentuating the therapeutic value of ACE inhibitors and ARBs in these individuals [113,114]. This evidence concerns the gene ACE and Hypertension.